Close

Repros Therapeutics (RPRX) Tops Q3 EPS by 7c

November 10, 2014 9:04 AM EST

Repros Therapeutics (NASDAQ: RPRX) reported Q3 EPS of ($0.32), $0.07 better than the analyst estimate of ($0.39).

For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings